Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H33NO2 |
Molecular Weight | 271.4387 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC(CCC)CCCC1COCCN1CCO
InChI
InChIKey=QSFOWAYMMZCQNF-UHFFFAOYSA-N
InChI=1S/C16H33NO2/c1-3-6-15(7-4-2)8-5-9-16-14-19-13-11-17(16)10-12-18/h15-16,18H,3-14H2,1-2H3
Molecular Formula | C16H33NO2 |
Molecular Weight | 271.4387 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Delmopinol, a surface-active cationic agent. It was approved by FDA under the name Decapinol for the treatment of gingivitis and prevention of periodontitis. The drug interacts with the early acquired pellicle, the thin layer of saliva polymers and proteins covering teeth and gums, and forms a barrier over teeth and gums. This barrier prevents the microbial adhesion and colonisation on the tooth and gum surface. Delmopinol itself has no bactericidal activity.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Dental pellicle |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | DECAPINOL Approved UseDECAPINOL is a novel, first in class, medical device to help treat gingivitis and prevent periodontitis by preventing the plaque formation on the teeth’s and gum’s surface. Launch Date2004 |
|||
Preventing | DECAPINOL Approved UseDECAPINOL is a novel, first in class, medical device to help treat gingivitis and prevent periodontitis by preventing the plaque formation on the teeth’s and gum’s surface. Launch Date2004 |
PubMed
Title | Date | PubMed |
---|---|---|
6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. | 1998 Sep |
|
An in vitro study on effect of Delmopinol application on Candida albicans adherence on heat cured denture base acrylic resin: a thorough study. | 2013 Sep-Oct |
|
In vitro study of the effect of an essential oil and a delmopinol mouth rinse on dental plaque bacteria. | 2016 Nov-Dec |
Sample Use Guides
Mouthwash formulation: Rinse 10ml of delmopinol (Decapinol mouthwash) for 30 sec and expectorate, use twice a day, avoid eating and drinking for about 30 minutes after the use of the mouthwash. Toothpaste formulation: Brush your teeth with delmopinol (decapinol toothpaste) as instructed by your dental professional.
Route of Administration:
Dental
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28169264
Bacteria isolated from samples of human dental plaque were treated with delmopinol mouthwash. Different dilutions of the delmopinol (100%, 50%, 25%, 12.5%, 6.25%, 3.12%, 1.56%, 0.78%, 0.39%, 0.19%) were tested to determine the MIC of bacterial growth. MIC values were 0.78% for Streptococcus mutants, 1.56% for Lactobacillus and 6.25 and 3.12 for aerobic and anaerobic bacterias, respectively.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:26:47 GMT 2023
by
admin
on
Fri Dec 15 17:26:47 GMT 2023
|
Record UNII |
DT67WL708F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C83486
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2104220
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY | |||
|
5586
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY | |||
|
m4154
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY | Merck Index | ||
|
C073738
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY | |||
|
C78112
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY | |||
|
79874-76-3
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY | |||
|
100000083707
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY | |||
|
3131
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY | |||
|
60451
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY | RxNorm | ||
|
57337
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY | |||
|
DT67WL708F
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY | |||
|
SUB06956MIG
Created by
admin on Fri Dec 15 17:26:47 GMT 2023 , Edited by admin on Fri Dec 15 17:26:47 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |